Strategic Investments Torrey Pines is a niche life-science investor with a focus on early development assets across CNS, oncology, and virology, presenting sales opportunities in portfolio diligence, co-development, and strategic partnerships with portfolio CRO networks.

Portfolio Collaboration The firm leverages its portfolio CRO resources to support development and regulatory strategy, offering potential services or partnerships for CROs, contract research networks, and translational research providers looking to align with investor-backed programs.

Recent Funded Deals Active participation in Series A rounds for Brenig Therapeutics and Mondego Bio signals ongoing deal flow and financing activity, suggesting opportunities to introduce biotech service providers, clinical development vendors, or potential co-investors.

Acceleration Programs Past engagement with i2020 Accelerator and translational R&D initiatives indicates appetite for program partnerships, technology scouting, and startup-to-commercialization support services that can be offered to early-stage companies.

San Diego Focus Based in San Diego with a specialized biotech investment thesis, there is an opportunity to connect with regional biotech vendors, clinical research organizations, and talent pipelines to support portfolio companies and expand the local ecosystem network.